Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

NCT06470451 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

CTCL/ Mycosis Fungoides
CTCL
Mycosis Fungoides
Cutaneous T Cell Lymphoma

Interventions

DRUG: Hypericin
DRUG: Placebo

Sponsor

Soligenix